Skip to content
Independent and accessible public media is needed more than ever.
Help us continue keeping communities informed and inspired.
Keep public media independent and accessible
Donate Now

View thank you gift options

CapRadio

CapRadio

signal status listen live donate
listen live donate signal status
listen live donate signal status
  • News
    • topics
    • State Government
    • Environment
    • Health Care
    • Race and Equity
    • Business
    • Arts and Lifestyle
    • Food and Sustainability
    • PolitiFact California
  • Music
    • genres
    • Classical
    • Jazz
    • Eclectic
    • Daily Playlist
  • Programs + Podcasts
    • news
    • Morning Edition
    • All Things Considered
    • Marketplace
    • Insight With Vicki Gonzalez
    • music
    • Acid Jazz
    • At the Opera
    • Classical Music
    • Connections
    • Excellence in Jazz
    • Hey, Listen!
    • K-ZAP on CapRadio
    • Mick Martin's Blues Party
    • Programs A-Z
    • Podcast Directory
  • Schedules
    • News
    • Music
    • ClassicalStream
    • JazzStream
    • Weekly Schedule
    • Daily Playlist
  • Community
    • Events Calendar
    • CapRadio Garden
    • CapRadio Reads
    • Ticket Giveaways
  • Support
    • Evergreen Gift
    • One-Time Gift
    • Corporate Support
    • Vehicle Donation
    • Stock Gift
    • Legacy Gift
    • Endowment Gift
    • Benefits
    • Member FAQ
    • e‑Newsletter
    • Drawing Winners
    • Thank You Gifts
  • About Us
  • Contact Us
  • Close Menu
 We Get Support From:
Become a Supporter 
 We Get Support From:
Become a Supporter 
  • State Government
  • Health Care
  •  

Should California Put $5.5 Billion Into Stem Cell Research? Voters To Decide With Prop. 14.

  •  Sammy Caiola 
Friday, September 18, 2020 | Sacramento, CA
Listen
/
Update RequiredTo play audio, update browser or Flash plugin.
AP Photo/Paul Sakuma

This March 16, 2012 photo shows researcher Terry Storm working in a stem cell research lab at the Lorry I. Lokey Stem Cell Research Building on the Stanford University campus in Palo Alto, Calif.

AP Photo/Paul Sakuma

A measure on the November ballot would allow California to issue $5.5 billion in bonds to fund stem cell research on treatments for cancer, Alzheimer’s and dozens of other diseases. Supporters say it’s a needed boost, but opponents say the move will unnecessarily increase California’s budget deficit. 

Proposition 14 would allow California to use bonds to fund the California Institute for Regenerative Medicine, which distributes grants to scientists for stem cell research. The institute was established in 2004, with $3 billion in state funding from voter-approved Proposition 71. 

If this November’s proposition fails, proponents of the institute say much of their research will be underfunded and potentially have to stop. Opponents of the measure say the federal government and private industries can fill the gaps.

Stem cells are valuable to scientists because they mature into the cells in bones, muscle, nerves and organs. They can be used to repair damaged tissues, test out new drugs or simply help researchers understand how diseases occur. 

Money from the institute is currently funding clinical trials for drugs that could help patients with Parkinson’s, leukemia and many other ailments. The organization says that in the past seven years, they’ve advanced more than 90 clinical trials, completed nearly 3,000 studies and backed two cancer treatments that have been approved by the U.S. Food and Drug Administration.

Lawrence Goldstein, a professor of neuroscience at the University of California, San Diego who conducts Alzheimer’s research supported by the institute, said these funds were crucial in launching what’s become a booming field. If Prop 14 fails, he says some of his ongoing projects could be in jeopardy.

“Government financing historically has made a big difference, and it will fund the steps in the clinical trial development process that we just can’t get private industry or the federal government to fund,” he said.

But that money from 2004 is running out. According to a report from the nonpartisan Legislative Analyst’s office, all but $132 million of the Proposition 71 funds had been spent as of October 2019. 

The institute asked scientists to stop applying for stem cell research grants in July 2019 because funds were depleted. They did make $5 million available for COVID-19 research grants in light of the pandemic.

While some researchers worry there will be a lack of stem cell funding should the proposition fail, opponents of the measure feel differently. They’re confident the federal government and private industry can pick up the slack. 

Jeff Sheehy is an AIDS activist and former San Francisco supervisor who sits on the board of the institute. When the board voted to endorse the proposition, he was the lone vote against it.

“Why does stem cell research suddenly deserve to have the state go into debt to fund it, when it’s amply funded on a federal level?” he said, citing other crucial needs such as housing and education. “It doesn’t make sense. Sure, if we could have everything, I would like a pony and a unicorn and a rainbow.”

The editorial board of The Bakersfield Californian argued that stem cell funding “would be unwise in these economically dire times.” The San Jose Mercury News and East Bay Times boards wrote that “it’s time for California’s stem-cell agency to continue its work as a self-sustaining non-profit or close down and allow federal grants and private business to push the industry forward.”

A Berkeley-based nonprofit called the Center for Genetics and Society filed an argument against the measure, citing concerns about accountability for how the institute spends its funds.

Federal grants for stem cell research have been restricted at various points due to ethical concerns over the use of embryonic stem cells. The Trump administration is currently making efforts to curtail the use of these cells.

Prop 14 supporters say federal funding is not a reliable way to sustain the California Institute for Regenerative Medicine’s work.

Goldstein, of UC San Diego, says while federal grants or private investments can sometimes be obtained for the early stages of research or to carry a therapy to the finish line, there’s a stretch in the middle — typically when a drug needs to be tested on animals — where funding is very hard to get.

“Yes, there’s lots of money sloshing around, but the ‘valley of death’ is still a real thing,” he said. 

And he says the trials currently being supported by the California Institute for Regenerative Medicine will likely not be picked up by other funders.

“Most of them will die on the vine,” he said. “They’ll have a hard time getting federal funds since many of them are still early, and there’s simply not enough private financing out there ... the cost rises as you get deeper and deeper into human trials.”

The Legislative Analyst’s Office estimates the total fiscal impact of Proposition 14 would be $7.8 billion, including interest on the bonds. They noted that the measure could ultimately save the state some money by reducing the prevalence of disease and creating more cost-effective treatments. 

The ballot measure also increases the number of people on the institute’s oversight committee and makes other structural changes.


Follow us for more stories like this

CapRadio provides a trusted source of news because of you.  As a nonprofit organization, donations from people like you sustain the journalism that allows us to discover stories that are important to our audience. If you believe in what we do and support our mission, please donate today.

Donate Today  

    More about Election 2020

  • Election 2020: Latest Results And Updates

    See all of CapRadio's coverage of the 2020 Election, including our guide to voting, explainers for all 12 statewide ballot measures and fact-checks on election misinformation.

 Election 2020Proposition 14Propositions 2020

Andrew Nixon / CapRadio

Sammy Caiola

Former Healthcare Reporter

Sammy Caiola has been covering medical breakthroughs, fitness fads and health policy in California since 2014. Before joining CapRadio, Sammy was a health reporter at The Sacramento Bee.  Read Full Bio 

 @sammycaiola Email Sammy Caiola

Sign up for ReCap and never miss the top stories

Delivered to your inbox every Friday.

 

Check out a sample ReCap newsletter.

Thanks for subscribing!

Thank you for signing up for the ReCap newsletter! We'll send you an email each Friday with the top stories from CapRadio.

Browse all newsletters

More State Government Stories

AP Photo/Rich Pedroncelli

Deal pulls California plastic trash measure from ballot

June 30, 2022

Andrew Nixon / CapRadio

California tax relief: What’s in the deal

June 26, 2022

AP Photo/Rich Pedroncelli

Let’s make a deal: What to know about the California budget

June 29, 2022

Most Viewed

Abortion is still legal in California. Here are answers to questions about access in the state.

Northern California wildfires: Where to find updates on air quality, evacuations, and official information

Composting starts soon in Sacramento County. Here’s what you need to know.

California coronavirus updates: FDA advisors recommend new formulation for COVID-19 booster shots

Homeless Sacramento residents could face misdemeanor for blocking sidewalks under city proposal

We Get Support From:
Become a Supporter

Most Viewed

Abortion is still legal in California. Here are answers to questions about access in the state.

Northern California wildfires: Where to find updates on air quality, evacuations, and official information

Composting starts soon in Sacramento County. Here’s what you need to know.

California coronavirus updates: FDA advisors recommend new formulation for COVID-19 booster shots

Homeless Sacramento residents could face misdemeanor for blocking sidewalks under city proposal

Back to Top

  • CapRadio

    7055 Folsom Boulevard
    Sacramento, CA 95826-2625

    • (916) 278-8900
    • Toll-free (877) 480-5900
    • Email Us
    • Submit a News Tip
  • Contact Us

  • About Us

    • Contact Us / Feedback
    • Coverage
    • Directions
    • Careers & Internships
    • Mission / Vision / Core Values
    • Press
    • Staff Directory
    • Board of Directors
  • Listening Options

    • Mobile App
    • On Air Schedules
    • Smart Speakers
    • Playlist
    • Podcasts
    • RSS
  • Connect With Us

    •  Facebook
    •  Twitter
    •  Instagram
    •  YouTube
  • Donate

  • Listen

  • Newsletters

CapRadio stations are licensed to California State University, Sacramento. © 2022, Capital Public Radio. All Rights Reserved. Privacy Policy | Website Feedback FCC Public Files: KXJZ KKTO KUOP KQNC KXPR KXSR KXJS. For assistance accessing our public files, please call 916-278-8900 or email us.